Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v2-FR
Language English French
Date Updated 2020-04-02 2019-12-19
Drug Identification Number 00550507 00550507
Brand name TEVA-TRIACOMB TEVA-TRIACOMB
Common or Proper name TRIACOMB CREAM TRIACOMB CREAM
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients TRIAMCINOLONE ACETONIDE NYSTATIN GRAMICIDIN NEOMYCIN TRIAMCINOLONE ACETONIDE NYSTATIN GRAMICIDIN NEOMYCIN
Strength(s) 1MG 100000UNIT 0.25MG 2.5MG 1MG 100000UNIT 0.25MG 2.5MG
Dosage form(s) CREAM CREAM
Route of administration TOPICAL TOPICAL
Packaging size 30g 30g
ATC code D07CB D07CB
ATC description CORTICOSTEROIDS, COMB WITH ANTIBIOTICS CORTICOSTEROIDS, COMB WITH ANTIBIOTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-12-18 2019-12-18
Estimated end date 2020-03-31 2020-03-31
Actual end date 2020-04-01
Shortage status Resolved Actual shortage
Company comments
Health Canada comments